Rationale and Design of the Cessation Of Pharmacotherapy In Recovered Chemotherapy-induced cardioToxicity (COP-RCT): A Pilot Study
- Creator: Yu, Christopher , Negishi, Tomoko , Pathan, Faraz , Sverdlov, Aaron , Thomas, Liza , Shirazi, Mitra , Koo, Chieh Yang , Tan, Li Ling , Miyazaki, Sakiko , Negishi, Kazuaki
- Resource Type: journal article
- Date: 2024
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society
- Creator: Lyon, Alexander R. , Dent, Susan , Stanway, Susannah , Earl, Helena , Brezden-Masley, Christine , Cohen-Solal, Alain , Tocchetti, Carlo G. , Moslehi, Javid J. , Groarke, John D. , Bergler-Klein, Jutta , Khoo, Vincent , Tan, Li Ling , Anker, Markus S. , von Haehling, Stephan , Maack, Christoph , Pudil, Radek , Barac, Ana , Thavendiranathan, Paaladinesh , Ky, Bonnie , Neilan, Tomas G. , Sverdlov, Aaron L.
- Resource Type: journal article
- Date: 2020